ReviewJournal of neuromuscular diseases2026

A historical perspective on the development of antisense oligonucleotide treatments for Duchenne muscular dystrophy and spinal muscular atrophy.

Annemieke Aartsma-Rus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.